Table 22.

—[Section 8.1] Summary of Findings: Should Statins Be Used to Prevent VTE?¹⁷⁰

Outcome	No. of Patients (Studies) Follow-up	Quality of the Evidence (GRADE)	Relative Effect (95% CI)	Anticipated Absolute Effects
				Baseline Risk	Risk Difference With Statins (95% CI)
Symptomatic DVT	17,802 (1 RCT) 1.9 y	High	HR, 0.45 (0.25-0.79)	4 per 1,000	2 fewer per 1,000 (from 1 fewer to 3 fewer)
Nonfatal PE	17,802 (1 RCT) 1.9 y	High	HR, 0.77 (0.41-1.45)	2 per 1,000	0 fewer per 1,000 (from 1 fewer to 1 more)

See Table 1 and 2 legends for expansion of abbreviations.